Flagship Pioneering

Flagship Pioneering

Flagship Pioneering

Overview
Date Founded

1982

Headquarters

1 MEMORIAL DRIVE, 7TH FLOOR, CAMBRIDGE, MA, 02142

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Private Equity & Venture Capital
Hospitals & Patient Services
Investment Services & Portfolio Management
Biotechnology

Company Description

Flagship Pioneering seeks investment opportunities in companies located globally. The firm focuses on companies operating in the fields of therapeutics, life science tools & diagnostics, and bioenergy or cleantech. It provides financing for seed, early, and later-stage capital requirements. It acts as a lead investor. It also makes co-investments.

Contact Data
Trying to get in touch with decision makers at Flagship Pioneering? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Founder

Chief Executive Officer & Partner

Managing Partner

Managing Partner

Senior Partner

Senior Partner

Senior Partner

Senior Partner, Capital Formation

Senior Partner & Chief Communications Officer

Senior Partner & Senior Vice President, Enterprise R&D & Operations

Board of Directors

Founder & Chairman at JAJAH, Inc.

Paths to Flagship Pioneering
Potential Connections via
Relationship Science
You
Flagship Pioneering
Recent Transactions
Details Hidden

Johnson & Johnson purchases TARIS BioMedical LLC from Polaris Partners, Flagship Pioneering, Third Rock Ventures LLC, Shanghai Yonghua Investment Management Ltd.

Details Hidden

Otsuka Pharmaceutical Co., Ltd., Otsuka Holdings Co., Ltd. purchase Visterra, Inc. from Polaris Partners, Flagship Pioneering, Lux Capital Group LLC, Cycad Group LLC, Merck Research Ventures, Vertex Ventures HC

Details Hidden

Synopsys, Inc. purchases Black Duck Software, Inc. from Focus Management, Inc., General Catalyst LLC, Flagship Pioneering, next47 Services GmbH, Gold Hill Capital Management LLC, Volition Capital LLC

Advisors & Consultants
Legal Advisor

Former Partner at Wilmer Cutler Pickering Hale and Dorr LLP

Clients

The Pension Reserves Investment Management Board employs external investment managers and gives them discretion, consistent with specified objectives and guidelines, to manage the Pension Reserves Investment Trust's assets. At reasonable intervals of not more than 3 to 5 years, the Board undertakes a comprehensive review of their asset allocation plan and its underlying assumptions, including Massachusetts' current and projected pension assets and liabilities, long-term capital markets rate of return assumptions and the Board's risk tolerances. The review identifies a reasonable time horizon and investment strategy for matching assets and liabilities, a fund level total return target and an optimal allocation among available asset classes and sub-asset classes. The Board examines the asset allocation plan annually, and considers adjustments to the plan as may be appropriate.

General Electric Pension Trust is a corporate fund investor in the United States. GE Pension Trust operates as a subsidiary of GE Asset Management Incorporated.

Non-Profit Donations & Grants
Investments
Details Hidden

Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines for cancer, autoimmune diseases, hemophilia, and infectious and metabolic diseases. The company was founded by Avak Kahvejian, Jordi Mata-Fink, and Noubar Afeyan on April 26, 2013 and is headquartered in Cambridge, MA.

Details Hidden

Indigo Agriculture, Inc. provides microbial solutions. The firm offers platform for microbiome product discovery and has generated a robust pipeline of candidates for seed, soil, and foliar applications in globally important crops, including corn, soy, wheat, cotton, and vegetables The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2014 and is headquartered in Boston, MA.

Details Hidden

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses in identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 13, 2018 and is headquartered in Seattle, WA.

Investors
Details Hidden

Co-Founder at Flagship Pioneering

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Flagship Pioneering. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Flagship Pioneering's profile does not indicate a business or promotional relationship of any kind between RelSci and Flagship Pioneering.